Pharmacogenetics and pharmacogenomics in rheumatology.

@article{Szekanecz2013PharmacogeneticsAP,
  title={Pharmacogenetics and pharmacogenomics in rheumatology.},
  author={Zolt{\'a}n Szekanecz and Bertalan Mesk{\'o} and Szil{\'a}rd P{\'o}liska and Andrea V{\'a}ncsa and Szilvia Szamosi and Edit V{\'e}gh and Enik{\"o} Simkovics and Judit Laki and J{\'u}lia Kurk{\'o} and Timea Besenyei and Katalin Mikecz and Tibor T. Glant and L{\'a}szl{\'o} Nagy},
  journal={Immunologic research},
  year={2013},
  volume={56 2-3},
  pages={325-33}
}
Pharmacogenetics and pharmacogenomics deal with possible associations of a single genetic polymorphism or those of multiple gene profiles with responses to drugs. In rheumatology, genes and gene signatures may be associated with altered efficacy and/or safety of anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs) and biologics. In brief, genes of cytochrome P450, other enzymes involved in drug metabolism, transporters and some cytokines have been associated with responses to… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Gene polymorphisms and therapy in rheumatoid arthritis.

Expert opinion on drug metabolism & toxicology • 2016
View 9 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…